1. Department of Reproductive Medicine Center, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, China 2. Department of Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Chemerin is a cytokine that attracts much attention in the reproductive process. This study aimed to explore the effects of chemerin and its receptor chemokine-like receptor 1 (CMKLR1) on the maintenance of early pregnancy. The expression levels of chemerin and CMKLR1 in the decidua tissues of 20 early normal pregnant women and 20 early spontaneous abortion women were examined by Western blot and real-time polymerase chain reaction analyses. CMKLR1 receptor antagonist (α-NETA) was then intrauterinely injected into normal pregnant mice model to assess its effect on the outcome of pregnancy and the phosphorylation rate of ERK1/2 in decidua tissues. We found that the expression level of chemerin in women who had experienced early spontaneous abortion was lower than in those who had experienced normal early pregnancy (P<0.01); conversely, CMKLR1 expression was higher in the former than in the latter (P<0.01). In a pregnant-mouse model, the embryo resorption rate of α-NETA group was higher than that in the negative control group (61.5% vs. 10.8%) (P<0.001). Compared with the control group, ERK1/2 phosphorylation in decidua tissues decreased in the α-NETA-treated group (P<0.01). These results suggested that the inhibition of the chemerin/CMKLR1 signaling pathway can lead to the abortion of mouse embryos, and that chemerin/CMKLR1 may play an important role in the maintenance of early pregnancy possibly by regulating ERK1/2 phosphorylation.
. [J]. Frontiers of Medicine, 2018, 12(5): 525-532.
Xuezhou Yang, Junning Yao, Qipeng Wei, Jinhai Ye, Xiaofang Yin, Xiaozhen Quan, Yanli Lan, Hui Xing. Role of chemerin/CMKLR1 in the maintenance of early pregnancy. Front. Med., 2018, 12(5): 525-532.
Saravelos SH, Cocksedge KA, Li TC. The pattern of pregnancy loss in women with congenital uterine anomalies and recurrent miscarriage. Reprod Biomed Online 2010; 20(3): 416–422 https://doi.org/10.1016/j.rbmo.2009.11.021
pmid: 20093084
Sugiura-Ogasawara M, Aoki K, Fujii T, Fujita T, Kawaguchi R, Maruyama T, Ozawa N, Sugi T, Takeshita T, Saito S. Subsequent pregnancy outcomes in recurrent miscarriage patients with a paternal or maternal carrier of a structural chromosome rearrangement. J Hum Genet 2008; 53(7): 622–628 https://doi.org/10.1007/s10038-008-0290-2
pmid: 18414779
5
Su MT, Lin SH, Chen YC. Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod Update 2011; 17(6): 803–812 https://doi.org/10.1093/humupd/dmr027
pmid: 21642294
6
Franssen MT, Musters AM, van der Veen F, Repping S, Leschot NJ, Bossuyt PM, Goddijn M, Korevaar JC. Reproductive outcome after PGD in couples with recurrent miscarriage carrying a structural chromosome abnormality: a systematic review. Hum Reprod Update 2011; 17(4): 467–475 https://doi.org/10.1093/humupd/dmr011
pmid: 21504961
Saravelos SH, Cocksedge KA, Li TC. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update 2008; 14(5): 415–429 https://doi.org/10.1093/humupd/dmn018
pmid: 18539641
9
Saravelos SH, Yan J, Rehmani H, Li TC. The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage. Hum Reprod 2011; 26(12): 3274–3279 https://doi.org/10.1093/humrep/der293
pmid: 21954281
10
Alijotas-Reig J, Ferrer-Oliveras R; EUROAPS Study Group. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report. Lupus 2012; 21(7): 766–768 https://doi.org/10.1177/0961203312440058
pmid: 22635227
Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 2012; 490(7418): 102–106 https://doi.org/10.1038/nature11462
pmid: 23023128
13
Tang AW, Alfirevic Z, Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod 2011; 26(8): 1971–1980 https://doi.org/10.1093/humrep/der164
pmid: 21613313
14
Davenport WB, Kutteh WH. Inherited thrombophilias and adverse pregnancy outcomes: a review of screening patterns and recommendations. Obstet Gynecol Clin North Am 2014; 41(1): 133–144 https://doi.org/10.1016/j.ogc.2013.10.005
pmid: 24491988
Corona-Meraz FI, Navarro-Hernandez RE, Ruiz-Quezada SL, Madrigal-Ruiz PM, Castro-Albarran J, Chavarria-Avila E, Guzman-Ornelas MO, Gomez-Banuelos E, Petri MH, Ramirez-Cedano JI, Aguilar-Aldrete ME, Rios-Ibarra C, Vazquez-Del Mercado M. Inverse relationship of the CMKLR1 relative expression and chemerin serum levels in obesity with dysmetabolic phenotype and insulin resistance. Mediators Inflamm 2016; 2016:3085390 https://doi.org/10.1155/2016/3085390
pmid: 27239101
17
Becker M, Rabe K, Lebherz C, Zugwurst J, Göke B, Parhofer KG, Lehrke M, Broedl UC. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 2010; 59(11): 2898–2903 https://doi.org/10.2337/db10-0362
pmid: 20724582
18
Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, Arner P, Eckel J. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009; 58(12): 2731–2740 https://doi.org/10.2337/db09-0277
pmid: 19720798
19
Kennedy AJ, Yang P, Read C, Kuc RE, Yang L, Taylor EJ, Taylor CW, Maguire JJ, Davenport AP. Chemerin elicits potent constrictor actions via chemokine-like receptor 1 (CMKLR1), not G-protein-coupled receptor 1 (GPR1), in human and rat vasculature. J Am Heart Assoc 2016; 5(10): e004421 https://doi.org/10.1161/JAHA.116.004421
pmid: 27742615
Dessein PH, Tsang L, Woodiwiss AJ, Norton GR, Solomon A. Circulating concentrations of the novel adipokine chemerin are associated with cardiovascular disease risk in rheumatoid arthritis. J Rheumatol 2014; 41(9): 1746–1754 https://doi.org/10.3899/jrheum.140122
pmid: 25028378
22
Samson M, Edinger AL, Stordeur P, Rucker J, Verhasselt V, Sharron M, Govaerts C, Mollereau C, Vassart G, Doms RW, Parmentier M. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol 1998; 28(5): 1689–1700 https://doi.org/10.1002/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I
pmid: 9603476
23
Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F, Communi D, Parmentier M, Majorana A, Sironi M, Tabellini G, Moretta A, Sozzani S. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007; 109(9): 3625–3632 https://doi.org/10.1182/blood-2006-08-038844
pmid: 17202316
24
Luangsay S, Wittamer V, Bondue B, De Henau O, Rouger L, Brait M, Franssen JD, de Nadai P, Huaux F, Parmentier M. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J Immunol 2009; 183(10): 6489–6499 https://doi.org/10.4049/jimmunol.0901037
pmid: 19841182
25
Garces MF, Sanchez E, Ruíz-Parra AI, Rubio-Romero JA, Angel-Müller E, Suarez MA, Bohórquez LF, Bravo SB, Nogueiras R, Diéguez C, Caminos JE. Serum chemerin levels during normal human pregnancy. Peptides 2013; 42: 138–143 https://doi.org/10.1016/j.peptides.2013.01.003
pmid: 23313148
26
Boutsikou T, Briana DD, Boutsikou M, Kafalidis G, Stamati L, Baka S, Hassiakos D, Gourgiotis D, Malamitsi-Puchner A. Cord blood chemerin and obestatin levels in large for gestational age infants. J Matern Fetal Neonatal Med 2013; 26(2): 123–126 https://doi.org/10.3109/14767058.2012.728648
pmid: 22963327
27
Garces MF, Sanchez E, Acosta BJ, Angel E, Ruíz AI, Rubio-Romero JA, Diéguez C, Nogueiras R, Caminos JE. Expression and regulation of chemerin during rat pregnancy. Placenta 2012; 33(5): 373–378 https://doi.org/10.1016/j.placenta.2012.02.007
pmid: 22369992
28
Carlino C, Trotta E, Stabile H, Morrone S, Bulla R, Soriani A, Iannitto ML, Agostinis C, Mocci C, Minozzi M, Aragona C, Perniola G, Tedesco F, Sozzani S, Santoni A, Gismondi A. Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy. J Clin Endocrinol Metab 2012; 97(10): 3603–3612 https://doi.org/10.1210/jc.2012-1102
pmid: 22791765
29
Duan DM, Niu JM, Lei Q, Lin XH, Chen X. Serum levels of the adipokine chemerin in preeclampsia. J Perinat Med 2011; 40(2): 121–127
pmid: 22117111
30
Wang Q, Leader A, Tsang BK. Inhibitory roles of prohibitin and chemerin in FSH-induced rat granulosa cell steroidogenesis. Endocrinology 2013; 154(2): 956–967 https://doi.org/10.1210/en.2012-1836
pmid: 23254195
31
Lee KJ, Shim SH, Kang KM, Kang JH, Park DY, Kim SH, Farina A, Shim SS, Cha DH. Global gene expression changes induced in the human placenta during labor. Placenta 2010; 31(8): 698–704 https://doi.org/10.1016/j.placenta.2010.05.006
pmid: 20554320
32
Trowsdale J, Betz AG. Mother’s little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 2006; 7(3): 241–246 https://doi.org/10.1038/ni1317
pmid: 16482172
33
Kyurkchiev D, Ivanova-Todorova E, Hayrabedyan S, Altankova I, Kyurkchiev S. Female sex steroid hormones modify some regulatory properties of monocyte-derived dendritic cells. Am J Reprod Immunol 2007; 58(5): 425–433 https://doi.org/10.1111/j.1600-0897.2007.00526.x
pmid: 17922695
34
Ivanova E, Kyurkchiev D, Altankova I, Dimitrov J, Binakova E, Kyurkchiev S. CD83 monocyte-derived dendritic cells are present in human decidua and progesterone induces their differentiation in vitro. Am J Reprod Immunol 2005; 53(4): 199–205 https://doi.org/10.1111/j.1600-0897.2005.00266.x
pmid: 15760381
35
Hashino M, Tachibana M, Nishida T, Hara H, Tsuchiya K, Mitsuyama M, Watanabe K, Shimizu T, Watarai M. Inactivation of the MAPK signaling pathway by Listeria monocytogenes infection promotes trophoblast giant cell death. Front Microbiol 2015; 6: 1145 https://doi.org/10.3389/fmicb.2015.01145
pmid: 26528279
36
Wang S, Cao C, Piao H, Li Y, Tao Y, Zhang X, Zhang D, Sun C, Zhu R, Wang Y, Yuan M, Li D, Du M. Tim-3 protects decidual stromal cells from toll-like receptor-mediated apoptosis and inflammatory reactions and promotes Th2 bias at the maternal-fetal interface. Sci Rep 2015; 5(1): 9013 https://doi.org/10.1038/srep09013
pmid: 25757669
37
Hu WT, Li MQ, Liu W, Jin LP, Li DJ, Zhu XY. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-kB and ERK1/2 signaling. Mol Hum Reprod 2014; 20(4): 358–372 https://doi.org/10.1093/molehr/gat094
pmid: 24344240
38
Zhu R, Huang YH, Tao Y, Wang SC, Sun Ch, Piao HL, Wang XQ, Du MR, Li DJ. Hyaluronan up-regulates growth and invasion of trophoblasts in an autocrine manner via PI3K/AKT and MAPK/ERK1/2 pathways in early human pregnancy. Placenta 2013; 34(9): 784–791 https://doi.org/10.1016/j.placenta.2013.05.009
pmid: 23806178
39
Xie KM, Hou XF, Li MQ, Li DJ. NME1 at the human maternal-fetal interface downregulates titin expression and invasiveness of trophoblast cells via MAPK pathway in early pregnancy. Reproduction 2010; 139(4): 799–808 https://doi.org/10.1530/REP-09-0490
pmid: 20145075
40
Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003; 9(2): 163–174 https://doi.org/10.1093/humupd/dmg013
pmid: 12751778